下垂体癌的临床特征:基于病例报告和文献综述的分析
Yongxiang Yang1, Wanlin Liang1,2, Kexia Fan1
1Department of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, China.
Frontiers in endocrinology
|November 15, 2024
概括
下垂体癌 (PC) 是一种罕见的,具有攻击性的瘤. 早期的指标,如特定激素分泌和遗传标志物,可以预测从垂体腺瘤 (PA) 的转变,指导治疗以获得更好的结果.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 神经外科 神经外科
背景情况:
- 下垂体癌 (PC) 是一种极其罕见的腺瘤的恶性瘤.
- 诊断是具有挑战性的,通常只有在检测到转移后才得到确认.
- 预后不佳需要更好地了解诊断和治疗.
相关概念视频
Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870
Cushing Syndrome I: Introduction
46
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
46
Cushing Syndrome II: Pathophysiology
56
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
56


